177 tracked 13F filers disclose a position in EYPT as of the latest SEC 13F filings, a combined $1.1B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | $106.9M | 8.3M | ▲+6.0% Added · +469K sh | Q1 2026 | |
| 2 | Cormorant Asset Management, LP | $106.5M | 8.3M | —Held | Q1 2026 | |
| 3 | BlackRock, Inc. | $92.5M | 7.2M | ▲+5.7% Added · +389K sh | Q1 2026 | |
| 4 | FEDERATED HERMES, INC. | $73.1M | 5.7M | ▼−5.8% Reduced · −348K sh | Q1 2026 | |
| 5 | FRANKLIN RESOURCES INC | $65.1M | 5.0M | ▲+1.4% Added · +72K sh | Q1 2026 | |
| 6 | JANUS HENDERSON GROUP PLC | $46.4M | 3.6M | ▲+23% Added · +663K sh | Q1 2026 | |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $45.9M | 3.6M | →First observed position No prior filed position | Q1 2026 | |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $42.5M | 3.3M | ▼−30% Reduced · −1.4M sh | Q1 2026 | |
| 9 | Paradigm Biocapital Advisors LP | $40.5M | 3.1M | ▼−15% Reduced · −549K sh | Q1 2026 | |
| 10 | Commodore Capital LP | $36.4M | 2.8M | ▲New +2.8M sh | Q1 2026 | |
| 11 | STATE STREET CORP | $33.7M | 2.4M | ▲+12% Added · +260K sh | Q2 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $29.5M | 2.1M | ▲+4.0% Added · +79K sh | Q2 2026 | |
| 13 | CITADEL ADVISORS LLC | $24.6M | 1.9M | ▲Added Added · +1.9M sh | Q1 2026 | |
| 14 | Aberdeen Group plc | $22.4M | 1.7M | ▲+8.2% Added · +132K sh | Q1 2026 | |
| 15 | BALYASNY ASSET MANAGEMENT L.P. | $18.5M | 1.4M | ▲+142% Added · +843K sh | Q1 2026 | |
| 16 | Parkman Healthcare Partners LLC | $17.5M | 1.4M | ▲+25% Added · +267K sh | Q1 2026 | |
| 17 | EVENTIDE ASSET MANAGEMENT, LLC | $16.1M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 18 | MORGAN STANLEY | $14.1M | 1.1M | ▲+390% Added · +872K sh | Q1 2026 | |
| 19 | ORBIMED ADVISORS LLC | $13.8M | 1.1M | ▼−57% Reduced · −1.4M sh | Q1 2026 | |
| 20 | 5AM Venture Management, LLC | $15.0M | 1.1M | —Held | Q2 2026 | |
| 21 | HSBC HOLDINGS PLC | $10.7M | 833K | ▲New +833K sh | Q1 2026 | |
| 22 | STEMPOINT CAPITAL LP | $10.5M | 811K | ▲+129% Added · +457K sh | Q1 2026 | |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | $10.2M | 794K | →First observed position No prior filed position | Q1 2026 | |
| 24 | Candriam S.C.A. | $11.3M | 788K | ▲+17% Added · +113K sh | Q2 2026 | |
| 25 | Artia Global Partners LP | $11.0M | 767K | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 13 funds opened a new position in EYPT and 26 added to an existing one, while 16 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 89 funds | $52.6B |
| META PLATFORMS INC-CLASS AMETA | 87 funds | $74.8B |
| INTUITIVE SURGICAL INCISRG | 87 funds | $19.5B |
| AMAZON.COM INCAMZN | 86 funds | $125.1B |
| MICRON TECHNOLOGY INCMU | 86 funds | $25.0B |
| BOSTON SCIENTIFIC CORPBSX | 85 funds | $9.4B |
| NVIDIA CORPNVDA | 84 funds | $260.5B |
| MICROSOFT CORPMSFT | 84 funds | $174.7B |
| LAM RESEARCH CORPLRCX | 83 funds | $22.9B |
| ROSS STORES INCROST | 83 funds | $7.4B |
| ALPHABET INC-CL AGOOGL | 82 funds | $103.2B |
| UNITEDHEALTH GROUP INCUNH | 82 funds | $19.5B |
Ranked by how many of EYPT's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Zaderej Karen L. | Director | Buy (P) | 11K | $52K |
| Jun 30, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell (S) | 2K | $37K |
| Jun 30, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell (S) | 2K | $37K |
| Apr 17, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell (S) | 2K | $37K |
| Mar 16, 2026 | Duker Jay S. | President and CEO, Director | Buy (P) | 2K | $20K |
| Mar 4, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell (S) | 2K | $44K |
| Feb 17, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell (S) | 2K | $37K |
| Jan 5, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell (S) | 43K | $728K |
| Dec 4, 2025 | Cormorant Asset Management, LP | Insider | Sell (S) | 60K | $942K |
| Dec 4, 2025 | Lurker Nancy | Director | Sell (S) | 9K | $141K |
| Nov 28, 2025 | Lurker Nancy | Director | Sell (S) | 500 | $7K |
| Nov 26, 2025 | Lurker Nancy | Director | Sell (S) | 200 | $3K |
Connected entities for EYPT
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/EYPT/capital-change-brief"
Use Arkolith's capital_change_brief for EYPT. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for EYPT. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.